Allspring Global Investments Holdings LLC Sells 10,167 Shares of LeMaitre Vascular, Inc. $LMAT

Allspring Global Investments Holdings LLC lowered its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 77.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,898 shares of the medical instruments supplier’s stock after selling 10,167 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in LeMaitre Vascular were worth $241,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Vanguard Personalized Indexing Management LLC bought a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at about $224,000. Johnson Investment Counsel Inc. raised its holdings in shares of LeMaitre Vascular by 0.7% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 29,639 shares of the medical instruments supplier’s stock valued at $2,462,000 after purchasing an additional 211 shares in the last quarter. KLP Kapitalforvaltning AS raised its holdings in shares of LeMaitre Vascular by 15.8% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 4,400 shares of the medical instruments supplier’s stock valued at $365,000 after purchasing an additional 600 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in shares of LeMaitre Vascular by 7.7% in the 2nd quarter. State of Alaska Department of Revenue now owns 12,214 shares of the medical instruments supplier’s stock valued at $1,014,000 after purchasing an additional 877 shares in the last quarter. Finally, Congress Asset Management Co. raised its holdings in shares of LeMaitre Vascular by 4.6% in the 2nd quarter. Congress Asset Management Co. now owns 673,968 shares of the medical instruments supplier’s stock valued at $55,973,000 after purchasing an additional 29,553 shares in the last quarter. Institutional investors own 84.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Cantor Fitzgerald boosted their price target on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the company a “neutral” rating in a report on Wednesday, August 6th. Barrington Research reiterated an “outperform” rating and set a $95.00 price objective on shares of LeMaitre Vascular in a research note on Wednesday, October 15th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of LeMaitre Vascular in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $97.60.

LeMaitre Vascular Stock Up 0.2%

NASDAQ:LMAT opened at $89.21 on Friday. The company has a market cap of $2.02 billion, a PE ratio of 43.31, a P/E/G ratio of 2.30 and a beta of 0.77. LeMaitre Vascular, Inc. has a twelve month low of $71.42 and a twelve month high of $109.58. The company has a current ratio of 13.96, a quick ratio of 11.74 and a debt-to-equity ratio of 0.46. The company’s 50 day moving average is $91.31 and its two-hundred day moving average is $86.77.

LeMaitre Vascular (NASDAQ:LMAT) last released its earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.03. The company had revenue of $63.15 million for the quarter, compared to the consensus estimate of $62.48 million. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. LeMaitre Vascular’s revenue was up 15.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.52 EPS. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 4th. Stockholders of record on Thursday, August 21st were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Thursday, August 21st. LeMaitre Vascular’s dividend payout ratio is 38.83%.

Insider Buying and Selling at LeMaitre Vascular

In other news, CEO George W. Lemaitre sold 100,000 shares of the company’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $93.51, for a total value of $9,351,000.00. Following the sale, the chief executive officer directly owned 1,727,003 shares of the company’s stock, valued at $161,492,050.53. This represents a 5.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bridget A. Ross sold 2,500 shares of the company’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $94.00, for a total transaction of $235,000.00. Following the completion of the sale, the director directly owned 2,916 shares in the company, valued at $274,104. This trade represents a 46.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,815 shares of company stock valued at $11,280,206 over the last quarter. Insiders own 9.50% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.